Tag: UK medicines regulation

UK MHRA orphan medicinal products regulatory approval process and rare disease treatment classification
Health PolicyPolicy & Systems

UK Orphan Drug Registry Expands Access to Rare Disease Treatments

The UK Medicines and Healthcare products Regulatory Agency (MHRA) maintains a comprehensive registry of authorised orphan medicinal products for rare…

By
GMJ Policy Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →